AZACITIDINE

NDC 55150-393 · Eugia US LLC

Generic nameAZACITIDINE

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS, SUBCUTANEOUS

Active ingredient(s)AZACITIDINE

Strength100 mg/4mL

Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]

Marketing categoryANDA

Packages

55150-393-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-393-01) / 4 mL in 1 VIAL, SINGLE-DOSE

Billed under HCPCS

J9025 — Injection, azacitidine, 1 mg Medicare Part B payment limit (ASP + 6%): $0.27

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0143-9606 — Azacitidine, 0781-3491 — Azacitidine, 16714-927 — Azacitidine, 16729-306 — Azacitidine, 31722-365 — Azacitidine, 43598-305 — Azacitidine, 43598-465 — Azacitidine, 43598-678 — AZACITIDINE, 43817-906 — Azacitidine, 58458-002 — Azacitidine, 59572-102 — azacitidine, 59572-730 — azacitidine, 59572-740 — azacitidine, 60505-6271 — azacitidine, 63323-771 — Azacitidine, 68001-313 — Azacitidine, 68001-527 — Azacitidine, 68001-620 — Azacitidine, 69539-112 — Azacitidine, 70069-857 — Azacitidine, +7 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources